scholarly journals The Maudsley Anorexia Nervosa Treatment for Adults (MANTRA): a feasibility case series of an integrated group based approach

2021 ◽  
Vol 9 (1) ◽  
Author(s):  
Helen Startup ◽  
Mary Franklin-Smith ◽  
William Barber ◽  
Nicola Gilbert ◽  
Yael Brown ◽  
...  

Abstract Background Individuals with Anorexia Nervosa (AN) typically struggle in social and emotional contexts. An Integrated Group Based approach for the delivery of MANTRA - The Maudsley Anorexia Nervosa Treatment for Adults – extends current NICE recommended therapy by augmenting treatment with opportunities for experiential practice in a group context. A feasibility case series, delivered across three NHS community services is presented. Methods The design was a case series of four Integrated Group MANTRA treatments delivered across three NHS sites (N = 29). Feasibility data of: retention, acceptability and effectiveness; alongside the qualitative capture of participant experiences of treatment is presented. Results Primary outcomes suggest treatment acceptability. Participants committed to treatment with only 2 dropouts. There was significant change with medium effect sizes for eating disorder cognitions and symptoms (as measured by the global score on EDEQ) and BMI. Core themes emerging from qualitative analysis captured the value of the relational aspect of the treatment, the incorporation of experiential methods, and the opportunity to draw on the support of the group members to reduce shame and stigma. Conclusions An Integrated Group based MANTRA approach is a feasible and effective alternative intervention for community Eating Disorder services.

2021 ◽  
Author(s):  
Helen Startup ◽  
Mary Franklin-Smith ◽  
William Barber ◽  
Nicola Gilbert ◽  
Yael Brown ◽  
...  

Abstract BackgroundIndividuals with Anorexia Nervosa (AN) typically struggle to negotiate their social and emotional worlds. Yet, current NICE recommended psychological therapies do not provide sufficient opportunities for live, in situ, relational and emotional experiences that enable growth in these areas. An Integrated Group Based approach for the delivery of MANTRA - The Maudsley Anorexia Nervosa Treatment for Adults - could address this omission by augmenting the treatment with group processes and live experiential practice. A feasibility case series of the approach, delivered across three NHS community services is presented.MethodsA case series design, comprising four Integrated Group MANTRA treatments delivered across three NHS sites (N=29), was used. Preliminary feasibility data is reported regarding: retention, acceptability and effectiveness; alongside the use of qualitative methods to capture participant experiences of treatment.ResultsPrimary outcomes suggest that Integrated Group MANTRA treatment was acceptable. Participants remained committed to the treatment with only 2 dropouts. Quantitative outcomes suggested significant change with medium effect sizes for both eating disorder cognitions and symptoms (as measured by the global score on EDEQ) and BMI. Five core themes emerged from qualitative analysis of participant feedback, capturing the value of the relational aspect of the treatment, the incorporation of experiential methods, and of the opportunity to draw on the support of the group members to reduce shame and stigma.ConclusionsPreliminary indication is that an Integrated Group based MANTRA approach is a feasible and effective alternative intervention for community Eating Disorder services.


2004 ◽  
Vol 14 (3) ◽  
pp. 353-360 ◽  
Author(s):  
Adriano Segal ◽  
Debora Kinoshita Kussunoki ◽  
Maria Aparecida Larino

1995 ◽  
Vol 166 (3) ◽  
pp. 386-389 ◽  
Author(s):  
R. J. Park ◽  
S. M. Lawrie ◽  
C. P. Freeman

BackgroundThe pathogenesis of anorexia nervosa (AN) is controversial.MethodA retrospective case series was studied to investigate the post-viral onset of AN.ResultsFour consecutive in-patients with severe restrictive AN spontaneously volunteered histories of ‘glandular fever’-like illnesses immediately before the onset of their eating disorder. This association has not previously been described. Possible pathogenic pathways include both non-specific and specific viral disruptions in central homeostasis, particularly involving corticotrophin-releasing hormone (CRH) regulation.ConclusionSuch mechanisms are speculative, but biologically and historically plausible.


2002 ◽  
Vol 6 (4) ◽  
pp. 345-353 ◽  
Author(s):  
Ingrid Tyler ◽  
Marni C. Wiseman ◽  
Richard I. Crawford ◽  
C. Laird Birmingham

Background and Objective: No complete review of the cutaneous manifestations of eating disorders exists. We therefore, set out to review and systematically describe the clinical and histopathologic features of dermatologic conditions associated with anorexia nervosa, bulimia nervosa, and obesity. Differential diagnosis, pathophysiology, laboratory studies, and treatment are also reviewed. Methods: Index Medicus review (1966 to present) using Ovid-MEDLINE. Search terms included eating disorders, anorexia nervosa, bulimia nervosa, eating disorders not otherwise specified (ED-NOS), and obesity, as well as the terms dermatology skin and cutaneous manifestations, with cross-referencing sources. These were combined with our own clinical experience. All relevant publications, including case reports, case series, cohort studies, and histopathologic studies giving at least Level II-3 evidence (evidence from comparisons between times or places with or without the intervention, including dramatic results in uncontrolled experiments), were selected. Conclusions: Forty dermatological signs have been reported in eating disorder patients. Eating disorders have many cutaneous manifestations and cutaneous signs may lead to the diagnosis of an occult eating disorder. The resolution of skin eruptions in eating disorder patients often depends on treatment of the underlying disorder.


Author(s):  
Susan McElroy ◽  
Anna I. Guerdjikova ◽  
Nicole Mori ◽  
Paul E. Keck

This chapter addresses the pharmacotherapy of the eating disorders (EDs). Many persons with EDs receive pharmacotherapy, but pharmacotherapy research for EDs has lagged behind that for other major mental disorders. This chapter first provides a brief rationale for using medications in the treatment of EDs. It then reviews the data supporting the effectiveness of specific medications or medication classes in treating patients with anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), and other potentially important EDs, such as night eating syndrome (NES). It concludes by summarizing these data and suggesting future areas for research in the pharmacotherapy of EDs.


Author(s):  
Pamela Keel

The epidemiology of eating disorders holds important clues for understanding factors that may contribute to their etiology. In addition, epidemiological findings speak to the public health significance of these deleterious syndromes. Information on course and outcome are important for clinicians to understand the prognosis associated with different disorders of eating and for treatment planning. This chapter reviews information on the epidemiology and course of anorexia nervosa, bulimia nervosa, and two forms of eating disorder not otherwise specified, binge eating disorder and purging disorder.


Sign in / Sign up

Export Citation Format

Share Document